Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response. Issue 5 (8th February 2021)

Record Type:
Journal Article
Title:
Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response. Issue 5 (8th February 2021)
Main Title:
Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response
Authors:
Yu, Miao
Terhorst‐Molawi, Dorothea
Altrichter, Sabine
Hawro, Tomasz
Chen, Yu‐Di
Liu, Bo
Song, Xiao‐ting
Zhao, Zuo‐tao
Maurer, Marcus
Abstract:
Is Part Of:
Clinical & experimental allergy. Volume 51:Issue 5(2021)
Journal:
Clinical & experimental allergy
Issue:
Volume 51:Issue 5(2021)
Issue Display:
Volume 51, Issue 5 (2021)
Year:
2021
Volume:
51
Issue:
5
Issue Sort Value:
2021-0051-0005-0000
Page Start:
730
Page End:
734
Publication Date:
2021-02-08
Subjects:
Allergy -- Periodicals
Immunology -- Periodicals
616.97
Journal URLs:
http://www.blackwellpublishing.com/journal.asp?ref=0954-7894&site=1 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2222 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:
10.1111/cea.13838 ↗
Languages:
English
ISSNs:
0954-7894
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 3286.249700
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
22523.xml